Microdosing GLP-1: Doses, Biomarkers & Provider Guidance

Last reviewed: May 17, 2026

Last updated: May 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

A GLP-1 microdose typically refers to initial or reduced-dose injections of 0.25 mg to 0.5 mg weekly—substantially lower than standard therapeutic doses of 2.4 mg. This approach prioritizes tolerability and metabolic observation before dose escalation.

Microdosing reflects a precision-wellness strategy: starting low allows providers to assess your individual response, monitor biomarkers, and adjust based on clinical and genetic context rather than population averages. Understanding this framework empowers informed conversations with your healthcare team.

What Constitutes a Microdose and Why It Matters

GLP-1 microdosing is not a formal FDA-defined term but rather a clinical practice of administering doses below standard induction protocols. Typical microdose ranges: 0.25 mg, 0.375 mg, or 0.5 mg weekly. These dosing steps allow providers to observe tolerability thresholds and metabolic response.

Microdosing serves multiple clinical purposes: reducing gastrointestinal side effects during initiation, establishing a baseline response before titration, and creating an individualized escalation pathway. This approach is particularly relevant for patients with metabolic sensitivity or medication intolerance history.

Microdose Protocols: Dose Levels, Timing, and Escalation Pathways

Microdosing protocols vary by clinical context and individual factors. Below is a framework showing common microdose steps and their typical timing before escalation to standard induction doses.

Microdose Level	Weekly Dose	Typical Duration	Next Escalation Step
Level 1 (Minimal)	0.25 mg	1–2 weeks	0.375 mg or 0.5 mg
Level 2 (Low Induction)	0.5 mg	2–4 weeks	1.0 mg or 1.5 mg
Level 3 (Standard Induction)	1.0 mg	3–4 weeks	1.5 mg
Level 4 (Maintenance Threshold)	1.5 mg or 2.0 mg	Ongoing or titration	2.4 mg (standard maintenance)

Biomarker Considerations That Inform Microdose Strategy

Microdosing decisions benefit from baseline biomarker assessment: fasting glucose, HbA1c, lipid panels, liver function, and gastrointestinal baseline symptoms. These markers help providers predict tolerability and establish a clinical baseline for monitoring response throughout titration.

Genetic predispositions in peptide signaling pathways—such as GLP1R, GIPR, and FTO variants—may provide context for metabolic sensitivity and dosing tolerance. While genetic data does not predict exact medication response, it can inform a provider's individualized escalation strategy and monitoring intensity.

Safety Profile, Contraindications, and Who Should Consider Microdosing

Microdosing is generally considered a cautious entry point for patients with history of medication sensitivity, gastrointestinal disorders, or comorbidities requiring gradual dose adjustment. Patients with personal or family history of medullary thyroid carcinoma or MEN2 should not use GLP-1 medications and should discuss alternatives with their provider.

Provider supervision is essential throughout microdosing protocols. Regular follow-up—typically weekly or biweekly during titration—ensures safety, monitors side effects, and confirms metabolic benefit before further dose increases. Shared decision-making with your healthcare team should guide every escalation decision.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context for how your body's peptide signaling pathways respond to GLP-1 treatment. Testing evaluates predispositions in GLP1R, GIPR, FTO, and MC4R variants—markers that can inform baseline tolerability expectations and personalized microdose strategies.

The genetic test reveals predispositions in peptide pathway function, not exact medication response. A provider interpreting your results can use this information to support more informed dosing discussions and anticipate which patients may benefit from extended microdosing protocols or closer metabolic monitoring.

Combining genetic insights with clinical biomarkers creates a richer clinical picture. This personalized context can help your provider move beyond standard escalation schedules to evidence-informed microdosing pathways tailored to your individual metabolic and genetic profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.